Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Roland Andersson, Ursula Aho, Bo I. Nilsson, Godefridus J. Peters, Marçal Pastor-Anglada, Wenche Rasch & Marit L. Sandvold. (2009) Gemcitabine chemoresistance in pancreatic cancer: Molecular mechanisms and potential solutions. Scandinavian Journal of Gastroenterology 44:7, pages 782-786.
Read now
Read now
Articles from other publishers (33)
Ryota Iwase, Hiroaki Shiba, Koichiro Haruki, Yuki Fujiwara, Kenei Furukawa, Yasuro Futagawa, Shigeki Wakiyama, Takeyuki Misawa & Katsuhiko Yanaga. (2022) Macroscopic Inflammation Status of Resected Gallbladder Predicts Therapeutic Outcome After Radical Resection for Gallbladder Carcinoma. International Surgery 106:4, pages 163-170.
Crossref
Crossref
Alina Tanţău, Daniel-Corneliu Leucuţa, Marcel Tanţău, Emil Boţan, Roxana Zaharie, Alina Mândruţiu & Ionuţ-Ciprian Tomuleasa. (2020) Inflammation, Tumoral Markers and Interleukin-17, -10, and -6 Profiles in Pancreatic Adenocarcinoma and Chronic Pancreatitis. Digestive Diseases and Sciences 66:10, pages 3427-3438.
Crossref
Crossref
Chen Yuan, Vicente Morales-Oyarvide, Natalia Khalaf, Kimberly Perez, Fred K Tabung, Gloria Y F Ho, Charles Kooperberg, Aladdin H Shadyab, Lihong Qi, Peter Kraft, Howard D Sesso, Edward L Giovannucci, JoAnn E Manson, Meir J Stampfer, Kimmie Ng, Charles S Fuchs, Brian M Wolpin & Ana Babic. (2021) Prediagnostic Inflammation and Pancreatic Cancer Survival. JNCI: Journal of the National Cancer Institute 113:9, pages 1186-1193.
Crossref
Crossref
Ala Litman-Zawadzka, Marta Łukaszewicz-Zając & Barbara Mroczko. (2019) Novel potential biomarkers for pancreatic cancer – A systematic review. Advances in Medical Sciences 64:2, pages 252-257.
Crossref
Crossref
A. Babic, N. Schnure, N. P. Neupane, M. M. Zaman, N. Rifai, M. W. Welch, L. K. Brais, D. A. Rubinson, V. Morales-Oyarvide, C. Yuan, S. Zhang, E. M. Poole, B. M. Wolpin, M. H. Kulke, D. A. Barbie, K. Wong, C. S. Fuchs & K. Ng. (2018) Plasma inflammatory cytokines and survival of pancreatic cancer patients. Clinical and Translational Gastroenterology 9:4, pages e145.
Crossref
Crossref
Daniel Ansari, Helmut Friess, Monika Bauden, Johan Samnegård & Roland Andersson. (2018) Pancreatic cancer: disease dynamics, tumor biology and the role of the microenvironment. Oncotarget 9:5, pages 6644-6651.
Crossref
Crossref
Maria Diab & Philip A. Philip. 2018. Current and Emerging Therapies in Pancreatic Cancer. Current and Emerging Therapies in Pancreatic Cancer
119
134
.
Daniel Åkerberg, Daniel Ansari, Roland Andersson & Bobby Tingstedt. (2017) The Effects of Surgical Exploration on Survival of Unresectable Pancreatic Carcinoma: A Retrospective Case-Control Study. Journal of Biomedical Science and Engineering 10:01, pages 1-9.
Crossref
Crossref
Takashi Murakami, Chikara Kunisaki, Shinichi Hasegawa, Jun Kimura, Ryo Takagawa, Takashi Kosaka, Hidetaka A. Ono, Hirochika Makino, Hirotoshi Akiyama & Itaru Endo. (2016) Postoperative infectious complications-driven recurrence after radical resection for esophageal cancer. Esophagus 13:4, pages 343-350.
Crossref
Crossref
Daniel Ansari, Roland Andersson, Monika P. Bauden, Bodil Andersson, Joanne B. Connolly, Charlotte Welinder, Agata Sasor & György Marko-Varga. (2014) Protein deep sequencing applied to biobank samples from patients with pancreatic cancer. Journal of Cancer Research and Clinical Oncology 141:2, pages 369-380.
Crossref
Crossref
Richard F. Knoop, Moritz Sparn, Jens Waldmann, Lars Plassmeier, Detlef K. Bartsch, Matthias Lauth, Christoph Hudemann & Volker Fendrich. (2014) Chronic Pancreatitis and Systemic Inflammatory Response Syndrome Prevent Impact of Chemotherapy with Gemcitabine in a Genetically Engineered Mouse Model of Pancreatic Cancer. Neoplasia 16:6, pages 463-470.
Crossref
Crossref
A. Alkhateeb, L. Zubritsky, B. Kinsman, K. Leitzel, C. Campbell-Baird, S. M. Ali, J. Connor & A. Lipton. (2014) Elevation in Multiple Serum Inflammatory Biomarkers Predicts Survival of Pancreatic Cancer Patients with Inoperable Disease. Journal of Gastrointestinal Cancer 45:2, pages 161-167.
Crossref
Crossref
E. Toh, J. Wilson, D. Sebag‐Montefiore & I. Botterill. (2014) Neutrophil:lymphocyte ratio as a simple and novel biomarker for prediction of locoregional recurrence after chemoradiotherapy for squamous cell carcinoma of the anus. Colorectal Disease 16:3.
Crossref
Crossref
Wanxing Duan, Xin Shen, Jianjun Lei, Qinhong Xu, Yongtian Yu, Rong Li, Erxi Wu & Qingyong Ma. (2014) Hyperglycemia, a Neglected Factor during Cancer Progression. BioMed Research International 2014, pages 1-10.
Crossref
Crossref
J Szkandera, M Stotz, G Absenger, T Stojakovic, H Samonigg, P Kornprat, R Schaberl-Moser, W AlZoughbi, C Lackner, A L Ress, F S Seggewies, A Gerger, G Hoefler & M Pichler. (2013) Validation of C-reactive protein levels as a prognostic indicator for survival in a large cohort of pancreatic cancer patients. British Journal of Cancer 110:1, pages 183-188.
Crossref
Crossref
Junhui Li, Gang Cao, Qingyong Ma, Han Liu, Wei Li & Liang Han. (2012) The bidirectional interation between pancreatic cancer and diabetes. World Journal of Surgical Oncology 10:1.
Crossref
Crossref
HE-QI BU, JIANG LUO, HUI CHEN, JIAN-HONG ZHANG, HONG-HAI LI, HONG-CHUN GUO, ZHAO-HONG WANG & SHENG-ZHANG LIN. (2012) Oridonin enhances antitumor activity of gemcitabine in pancreatic cancer through MAPK-p38 signaling pathway. International Journal of Oncology 41:3, pages 949-958.
Crossref
Crossref
Jai Young Cho, Ho‐Seong Han, Yoo‐Seok Yoon, Dae Wook Hwang, Kyuwhan Jung, Ji Hoon Kim, Yujin Kwon & Haeryoung Kim. (2012) Preoperative Cholangitis and Metastatic Lymph Node Have a Negative Impact on Survival After Resection of Extrahepatic Bile Duct Cancer. World Journal of Surgery 36:8, pages 1842-1847.
Crossref
Crossref
Rene Warschkow, Kristjan Ukegjini, Ignazio Tarantino, Thomas Steffen, Sascha A. Müller, Bruno M. Schmied & Lukas Marti. (2011) Diagnostic study and meta‐analysis of C‐reactive protein as a predictor of postoperative inflammatory complications after pancreatic surgery. Journal of Hepato-Biliary-Pancreatic Sciences 19:4, pages 492-500.
Crossref
Crossref
Y Nagasako, S Satoh, J Isogaki, K Inaba, K Taniguchi & I Uyama. (2012) Impact of anastomotic complications on outcome after laparoscopic gastrectomy for early gastric cancer. British Journal of Surgery 99:6, pages 849-854.
Crossref
Crossref
Giuseppe Garcea, Vaux Cairns, David P. Berry, Christopher P. Neal, Matthew S. Metcalfe & Ashley R. Dennison. (2012) Improving the Diagnostic Yield From Staging Laparoscopy for Periampullary Malignancies. Pancreas 41:2, pages 233-237.
Crossref
Crossref
Matthias M. Gaida, Thilo Welsch, Esther Herpel, Darjus F. Tschaharganeh, Lars Fischer, Peter Schirmacher, G. Maria Hänsch & Frank Bergmann. (2011) MHC class II expression in pancreatic tumors: a link to intratumoral inflammation. Virchows Archiv 460:1, pages 47-60.
Crossref
Crossref
Rahul S. Koti & Brian R. Davidson. 2011. Sherlock's Diseases of the Liver and Biliary System. Sherlock's Diseases of the Liver and Biliary System
294
311
.
G. Garcea, N. Ladwa, C. P. Neal, M. S. Metcalfe, A. R. Dennison & D. P. Berry. (2011) Preoperative Neutrophil‐to‐Lymphocyte Ratio (NLR) is Associated with Reduced Disease‐free Survival Following Curative Resection of Pancreatic Adenocarcinoma. World Journal of Surgery 35:4, pages 868-872.
Crossref
Crossref
Jason B. Douglas, Debra T. Silverman, Stephanie J. Weinstein, Barry I. Graubard, Michael N. Pollak, Yuzhen Tao, Jarmo Virtamo, Demetrius Albanes & Rachael Z. Stolzenberg-Solomon. (2011) Serum C-Reactive Protein and Risk of Pancreatic Cancer in Two Nested, Case–Control Studies. Cancer Epidemiology, Biomarkers & Prevention 20:2, pages 359-369.
Crossref
Crossref
H-S Han, J Y Cho, Y-S Yoon, K S Ahn & H Kim. (2011) Preoperative inflammation is a prognostic factor for gallbladder carcinoma. British Journal of Surgery 98:1, pages 111-116.
Crossref
Crossref
A. Bartosch-Härlid & R. Andersson. (2010) Diabetes Mellitus in Pancreatic Cancer and the Need for Diagnosis of Asymptomatic Disease. Pancreatology 10:4, pages 423-428.
Crossref
Crossref
Donald C. McMillan. 2010. Pancreatic Disease. Pancreatic Disease
97
102
.
Barbara Mroczko, Magdalena Groblewska, Mariusz Gryko, Bogusław Kędra & Maciej Szmitkowski. (2010) Diagnostic usefulness of serum interleukin 6 (IL‐6) and C‐reactive protein (CRP) in the differentiation between pancreatic cancer and chronic pancreatitis. Journal of Clinical Laboratory Analysis 24:4, pages 256-261.
Crossref
Crossref
A. Bartosch-Härlid & R. Andersson. (2009) Cachexia in pancreatic cancer – Mechanisms and potential intervention. e-SPEN, the European e-Journal of Clinical Nutrition and Metabolism 4:6, pages e337-e343.
Crossref
Crossref
J.K. Pine, K.G. Fusai, R. Young, D. Sharma, B.R. Davidson, K.V. Menon & S.H. Rahman. (2009) Serum C-reactive protein concentration and the prognosis of ductal adenocarcinoma of the head of pancreas. European Journal of Surgical Oncology (EJSO) 35:6, pages 605-610.
Crossref
Crossref
Johan Ingvarsson, Christer Wingren, Anders Carlsson, Peter Ellmark, Britta Wahren, Gunnel Engström, Ulrika Harmenberg, Morten Krogh, Carsten Peterson & Carl A. K. Borrebaeck. (2008) Detection of pancreatic cancer using antibody microarray‐based serum protein profiling. PROTEOMICS 8:11, pages 2211-2219.
Crossref
Crossref
Colin J. McKay, Paul Glen & Donald C. McMillan. (2008) Chronic inflammation and pancreatic cancer. Best Practice & Research Clinical Gastroenterology 22:1, pages 65-73.
Crossref
Crossref